AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript November 2, 2023
AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.14.
Operator: Good afternoon, and welcome to AbCellera’s Third Quarter 2023 Business Update Conference Call. My name is Kate, and I will facilitate the audio portion of today’s interactive broadcast. [Operator Instructions] At this time, I would like to turn the call over to Tryn Stimart, AbCellera’s Chief...
